Plus Therapeutics, Inc.
PSTV
$0.5526
-$0.0753-11.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.15M | -17.40M | -3.90M | -2.87M | -2.94M |
| Total Depreciation and Amortization | 77.00K | 146.00K | 103.00K | 232.00K | 170.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 4.00K |
| Total Other Non-Cash Items | -6.52M | 12.52M | 216.00K | -882.00K | -990.00K |
| Change in Net Operating Assets | -4.50M | -1.44M | 2.37M | -156.00K | 2.61M |
| Cash from Operations | -5.80M | -6.17M | -1.21M | -3.68M | -1.15M |
| Capital Expenditure | -7.00K | -3.00K | -11.00K | -14.00K | -81.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 30.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.63M | 3.53M | 75.00K | 5.00K | -3.72M |
| Cash from Investing | -4.63M | 3.56M | 64.00K | -9.00K | -3.80M |
| Total Debt Issued | 0.00 | 3.74M | 0.00 | 0.00 | 3.29M |
| Total Debt Repaid | 0.00 | -7.00M | 0.00 | 0.00 | -3.59M |
| Issuance of Common Stock | 3.02M | 15.66M | 0.00 | 0.00 | 7.31M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.00K | -- | -- | -- | -45.00K |
| Cash from Financing | 2.80M | 12.41M | 0.00 | 0.00 | 6.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.63M | 9.79M | -1.15M | -3.69M | 2.01M |